how are glp-1 drugs manufactured The boom: Challenges, trends, and CapEx strategies for manufacturers Market Overview: GLP-1 Agonists and

The work was supported by the state task of the National Almazov Medical Research Center No

2012;7:e36569

At a glance Drug / dulaglutide (Trulicity), a once-weekly subcutaneous GLP-1 receptor agonist Approved dose range / 0.75 mg to 4.5 mg once weekly (subcutaneous injection) Glutathione forms / oral, liposomal oral, sublingual, inhaled, intravenous (IV) Interaction classification / no known pharmacokinetic interaction

Half were treated with oral approaches, and half were treated with Faecal Microbiome Transplantation

Animal Ethics and All Procedures Ethics approval was provided by the Animal Ethics Committee of Joint Service Support Force 940 Hospital of PLA